arrow
N

Niels Reinmuth

Department of Thoracic Oncology
H指数:58
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COPD Severity as an Independent Predictor of Long-Term Survival in Operable Lung Cancer: A Retrospective Analysis from a High-Volume Thoracic Surgery Center

COPD严重程度作为可手术肺癌长期生存的独立预测因子:一项来自高容量胸外科中心的回顾性分析

2025-09-040
OAAI
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study

度伐利尤单抗联合铂类-依托泊苷治疗广泛期小细胞肺癌:CASPIAN III期研究中不同年龄、性别和铂类亚组的结果

2025-08-050
OAAI
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)

重新评估针对非小细胞肺癌的姑息性放疗联合PD-1阻断疗法:FORCE II期试验(AIO/YMO-TRK-0415)的结果

2025-07-240
OAAI
Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

德国国家基因组医学网络(nNGM)肺癌项目中,BRAF非-V600E突变型非小细胞肺癌患者的治疗效果:一项回顾性、多中心分析

2025-07-140
OAAI
Prospective assessment of MR-guided single-fraction stereotactic ablative radiotherapy for peripheral lung metastases: dosimetric and clinical outcomes

MR引导下单次分割立体定向消融放射治疗周围型肺转移瘤的前瞻性评估:剂量学及临床结果

2025-06-040
PREAI
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

EVOKE-01研究:沙库巴曲韦他尼 vs 多西他赛在非小细胞肺癌患者中的疗效对比的简明摘要

2025-05-150
OA
Electric-Field Molecular Fingerprinting to Probe Cancer

电场分子指纹技术在癌症探查中的应用

2025-04-091
OA
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

在CheckMate 9LA随机试验中,转移性非小细胞肺癌患者一线nivolumab联合ipilimumab进行2周期化疗与单独4周期化疗的五年结果

2024-11-012
OAAI
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

Durvalumab加或不加Tremelimumab联合化疗作为转移性非小细胞肺癌一线治疗的简要报告: POSEIDON 3期研究中肿瘤PD-L1表达的结果

2024-05-013
OAAI
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

Sotorasib在KRAS G12C-mutated非小细胞肺癌: 来自德国同情使用计划的多中心现实世界经验

2024-04-018
OA
Plasma proteomics-based models for predicting therapeutic benefit and immunerelated adverse events in non-small cell lung cancer patients treated with immunotherapy
2024-03-220
PRE
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

免疫治疗非小细胞肺癌患者血浆蛋白质组学的生物学见解

2024-02-293
OAAI
ALBA project: Prognostic impact of laterality in small cell lung cancer

ALBA项目: 偏侧性对小细胞肺癌预后的影响

2023-10-010
OAAI